PRVA Privia Health Group, Inc.
Services-Health Services · Nasdaq · SEC CIK 1759655 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY19.2%
TTM net income YoY91.3%
TTM EPS YoY85.7%
Revenue 3-yr CAGR15.5%
Net income 3-yr CAGR-3.0%
Margins
Gross margin—
Operating margin2.1%
Net margin1.4%
FCF margin—
EBITDA margin2.6%
Returns
ROE4.6%
ROA2.4%
ROIC (approx.)10.0%
Asset turnover1.67x
Leverage & solvency
Liabilities / assets44.2%
Debt / equity0.00x
Current ratio1.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.11x
Accruals ratio-5.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.22M |
| SG&A expense | $138.15M | $126.16M | $109.59M | $129.59M | $255.88M |
| Operating income | $34.23M | $16.98M | $20.65M | -$19.12M | -$217.44M |
| Interest expense | — | — | — | $500,000 | $1.10M |
| Pretax income | $43.94M | $27.87M | $29.02M | -$18.58M | -$218.51M |
| Income tax | $14.21M | $10.83M | $7.99M | -$6.52M | -$27.86M |
| Net income | $22.92M | $14.38M | $23.08M | -$8.59M | -$188.23M |
| EBITDA | $44.14M | $24.25M | $27.18M | -$14.55M | -$214.97M |
| EPS (basic) | 0.19 | 0.12 | 0.20 | -0.08 | -1.83 |
| EPS (diluted) | 0.18 | 0.11 | 0.19 | -0.08 | -1.83 |
| Weighted avg. shares (diluted) | 128.89M | 125.61M | 124.69M | 110.70M | 102.95M |
| Banking | |||||
| Net interest income | — | — | $8.37M | $542,000 | -$1.07M |
| Balance sheet | |||||
| Cash & equivalents | $479.69M | $491.15M | $389.51M | $347.99M | $320.58M |
| Receivables | $400.90M | $316.18M | $290.77M | $189.60M | $117.40M |
| Current assets | $911.00M | $834.82M | $700.80M | $551.96M | $446.68M |
| PP&E, net | $504,000 | $1.24M | $2.33M | $3.39M | $4.50M |
| Goodwill | $209.84M | $141.62M | $138.75M | $126.94M | $127.94M |
| Intangibles | $215.92M | $109.81M | $107.63M | $57.39M | $59.74M |
| Total assets | $1.37B | $1.14B | $999.90M | $792.81M | $686.37M |
| Current liabilities | $568.52M | $449.15M | $386.95M | $264.27M | $190.46M |
| Total liabilities | $578.43M | $452.34M | $392.51M | $273.76M | $236.19M |
| Shareholders' equity | $737.22M | $635.18M | $561.44M | $499.09M | $426.87M |
| Shares outstanding | 123.60M | 120.31M | 118.22M | 114.69M | 107.84M |
| Cash flow statement | |||||
| Operating cash flow | $163.40M | $109.28M | $80.78M | $47.20M | $55.06M |
| Capital expenditure | — | — | $113,000 | $104,000 | $547,000 |
| Free cash flow | — | — | $80.67M | $47.09M | $54.51M |
| Investing cash flow | -$181.57M | -$11.98M | -$42.97M | -$104,000 | -$32.77M |
| Financing cash flow | $6.70M | $4.33M | $3.71M | -$19.68M | $213.66M |
| Depreciation & amortization | $9.91M | $7.27M | $6.53M | $4.57M | $2.46M |
| Stock-based compensation | $71.07M | $56.68M | $37.10M | $67.36M | $253.53M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.